Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd. has announced an accelerated non-renounceable entitlement offer to raise approximately A$10 million. The offer, priced at A$0.038 per new share, is available to eligible shareholders in Australia and New Zealand who were shareholders as of the record date and not part of the Institutional Entitlement Offer. The entitlement is not extended to ineligible shareholders, resulting in potential dilution of their shareholdings.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
